PHAR
Pharming Group NV
NASDAQ: PHAR · HEALTHCARE · BIOTECHNOLOGY
$12.98
+8.17% today
Updated 2026-05-08
Market cap
$847.50M
P/E ratio
300.00
P/S ratio
2.29x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$9 – $21
Volume
0.0M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+6.3
Quality
B4.0
Profitability
C5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$34.60
+166.56%
12-Month target
$1.87
-85.59%
Intrinsic (DCF)
$18.40
Margin of safety
+15.38%
0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $7.12M — positive
+ 15.38% below intrinsic value
Risks
- Altman Z 1.49 — distress zone
- Thin margins at 3.34%
- Revenue declining -8.40% QoQ
- P/E 300.00x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $205.62M | $245.32M | $297.20M | $377.18M | $369.49M |
| Net income | $13.67M | $-10.55M | $-11.84M | $2.86M | $5.29M |
| EPS | — | — | — | — | $0.04 |
| Free cash flow | $20.48M | $-18.77M | $-2.59M | $49.31M | $7.12M |
| Profit margin | 6.65% | -4.30% | -3.98% | 0.76% | 3.34% |
Peer comparison
Smart narrative
Pharming Group NV trades at $12.98. representing a P/E of 300.00x trailing earnings. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.49, it sits in the distress. TTM revenue stands at $369.49M. with profit margins at 3.34%. Our DCF model estimates intrinsic value at $18.40.
Frequently asked questions
What is Pharming Group NV's stock price?
Pharming Group NV (PHAR) trades at $12.98.
Is Pharming Group NV overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $18.40.
What is the price target of Pharming Group NV (PHAR)?
The analyst target price is $34.60, representing +166.6% upside from the current price of $12.98.
What is the intrinsic value of Pharming Group NV (PHAR)?
Based on our DCF model, intrinsic value is $18.40, a +15.4% margin of safety versus $12.98.
What is Pharming Group NV's revenue?
TTM revenue is $369.49M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
1.49 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.29x
ROE5.04%
Beta0.12
50D MA$16.28
200D MA$15.58
Shares out0.07B
Float0.73B
Short ratio—
Avg volume0.0M
Performance
1 week-29.33%
1 month-29.33%
3 months-25.42%
YTD-32.09%
1 year—
3 years—
5 years—